Survey on cannabis use in Parkinson's disease: subjective improvement of motor symptoms.

@article{Venderov2004SurveyOC,
  title={Survey on cannabis use in Parkinson's disease: subjective improvement of motor symptoms.},
  author={Katerina Venderov{\'a} and Ev{\vz}en Rů{\vz}i{\vc}ka and Viktor Voř{\'i}{\vs}ek and Peter Vi{\vs}ňovsk{\'y}},
  journal={Movement disorders : official journal of the Movement Disorder Society},
  year={2004},
  volume={19 9},
  pages={
          1102-6
        }
}
An anonymous questionnaire sent to all patients attending the Prague Movement Disorder Centre revealed that 25% of 339 respondents had taken cannabis and 45.9% of these described some form of benefit. 

Tables and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 54 CITATIONS, ESTIMATED 45% COVERAGE

Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection

VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Phytocannabinoids as novel therapeutic agents in CNS disorders.

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Cannabis Therapeutics and the Future of Neurology

VIEW 2 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Medical Cannabis in Parkinson Disease: Real-Life Patients' Experience

VIEW 4 EXCERPTS
CITES METHODS
HIGHLY INFLUENCED

Drugs of abuse and Parkinson's disease

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2006
2019

CITATION STATISTICS

  • 8 Highly Influenced Citations

  • Averaged 6 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES

Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.